Skip to content
HORMONES (Archive)
  • HOME
  • ARCHIVE
    • VOLUME 16 (2017)
    • VOLUME 15 (2016)
    • VOLUME 14 (2015)
    • VOLUME 13 (2014)
    • VOLUME 12 (2013)
    • VOLUME 11 (2012)
    • VOLUME 10 (2011)
    • VOLUME 9 (2010)
    • VOLUME 8 (2009)
    • VOLUME 7 (2008)
    • VOLUME 6 (2007)
      • Issue 1 (January-March)61
      • Issue 2 (April-June)62
    • VOLUME 5 (2006)
      • Issue 1 (January-March)51
      • Issue 2 (April-June)52
    • VOLUME 4 (2005)
      • Issue 1 (January-March)41
      • Issue 2 (April-June)42
    • VOLUME 3 (2004)
    • VOLUME 2 (2003)
    • VOLUME 1 (2002)
      • Issue 1 (January-March)
      • Issue 2 (April-June)12
      • Issue 3 (July-September)13
      • Issue 4 (October- December)14
  • SEARCH
  • CONTACT US

Tag: Cabergoline

What causes a prolactinoma to be aggressive or to become a pituitary carcinoma?

Posted on by

Read More

Posted in Issue 4 (October- December), Journal Articles, Volume 11 (2012) Tagged Cabergoline, Pituitary carcinoma, Prolactin, Temozolomide Leave a comment

Brain and optic chiasmal herniation following cabergoline treatment for a giant prolactinoma: wait or intervene?

Posted on by

Read More

Posted in Issue 2 (April - June), Journal Articles, Volume 13 (2014) Tagged Brain herniation, Cabergoline, Giant prolactinoma, Optic chiasmal herniation, Visual deterioration Leave a comment

Cabergoline treatment for recurrent Cushing’s disease during pregnancy

Posted on by

Read More

Posted in Issue 3 (July-September), Journal Articles, Volume 15 (2016) Tagged Cabergoline, Cushing's disease, pregnancy Leave a comment

Temozolomide therapy for resistant prolactin-secreting pituitary adenomas and carcinomas: a systematic review

Posted on by

Read More

Posted in Issue 2 (April - June), Journal Articles, Volume 16 (2017) Tagged Bromocriptine, Cabergoline, Dopamine agonist, Prolactinoma, Resistance, Temozolomide Leave a comment
Theme by Out the Box